U01EB026414
Cooperative Agreement
Overview
Grant Description
Biomechanical approaches and technologies for enhancing TAVR outcomes.
Funding Goals
TO SUPPORT HYPOTHESIS-, DESIGN-, TECHNOLOGY-, OR DEVICE-DRIVEN RESEARCH RELATED TO THE DISCOVERY, DESIGN, DEVELOPMENT, VALIDATION, AND APPLICATION OF TECHNOLOGIES FOR BIOMEDICAL IMAGING AND BIOENGINEERING. THE PROGRAM INCLUDES BIOMATERIALS (BIOMIMETICS, BIOPROCESSING, ORGANOGENESIS, REHABILITATION, TISSUE ENGINEERING, IMPLANT SCIENCE, MATERIAL SCIENCE, INTERFACE SCIENCE, PHYSICS AND STRESS ENGINEERING, TECHNOLOGY ASSESSMENT OF MATERIALS/DEVICES), BIOSENSORS/BIOTRANSDUCERS (TECHNOLOGY DEVELOPMENT, TECHNOLOGY ASSESSMENT, DEVELOPMENT OF ALGORITHMS, TELEMETRY), NANOTECHNOLOGY (NANOSCIENCE, BIOMIMETICS, DRUG DELIVERY SYSTEMS, DRUG BIOAVAILABILITY, MICROARRAY/COMBINATORIAL TECHNOLOGY, GENETIC ENGINEERING, COMPUTER SCIENCE, TECHNOLOGY ASSESSMENT), BIOINFORMATICS (COMPUTER SCIENCE, INFORMATION SCIENCE, MATHEMATICS, BIOMECHANICS, COMPUTATIONAL MODELING AND SIMULATION, REMOTE DIAGNOSIS AND THERAPY), IMAGING DEVICE DEVELOPMENT, BIOMEDICAL IMAGING TECHNOLOGY DEVELOPMENT, IMAGE EXPLOITATION, CONTRAST AGENTS, INFORMATICS AND COMPUTER SCIENCES RELATED TO IMAGING, MOLECULAR AND CELLULAR IMAGING, BIOELECTRICS/BIOMAGNETICS, ORGAN AND WHOLE BODY IMAGING, SCREENING FOR DISEASES AND DISORDERS, AND IMAGING TECHNOLOGY ASSESSMENT AND SURGERY (TECHNIQUE DEVELOPMENT AND TECHNOLOGY DEVELOPMENT).
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 05/31/23 to 12/31/24 and the total obligations have increased 390% from $781,199 to $3,825,145.
The Research Foundation For The State University Of New York was awarded
Biomechanical Approaches and Technologies for Enhancing TAVR Outcomes
Cooperative Agreement U01EB026414
worth $3,825,145
from the National Institute of Biomedical Imaging and Bioengineering in September 2018 with work to be completed primarily in New York United States.
The grant
has a duration of 6 years 3 months and
was awarded through assistance program 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health.
The Cooperative Agreement was awarded through grant opportunity Bioengineering Research Partnerships (U01).
Status
(Complete)
Last Modified 5/20/25
Period of Performance
9/15/18
Start Date
12/31/24
End Date
Funding Split
$3.8M
Federal Obligation
$0.0
Non-Federal Obligation
$3.8M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01EB026414
Transaction History
Modifications to U01EB026414
Additional Detail
Award ID FAIN
U01EB026414
SAI Number
U01EB026414-124774168
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Funding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Awardee UEI
M746VC6XMNH9
Awardee CAGE
3GPV4
Performance District
NY-90
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Health and Human Services (075-0898) | Health research and training | Grants, subsidies, and contributions (41.0) | $4,624,963 | 100% |
Modified: 5/20/25